news, journals and articles from all over the world.
Researchers uncovered how stanniocalcin-1, or STC1, works inside a tumor cell to block a cellular “eat-me” signal that typically triggers the immune system to produce T cells to fight the tumor. The findings provide a potential target to improve immune responses to cancer.
Experts trained a computer to tell which skin cancer patients may benefit from drugs that keep tumors from shutting down the immune system’s attack on them, a new study finds.
Researchers in China have discovered how brain cancer cells increase production of a key protein that allows them to evade the body’s immune system. The study, which will be published August 27 in the Journal of Experimental Medicine (JEM), suggests that targeting this cellular pathway could help treat the deadly brain cancer glioblastoma, as well as other cancers that are resistant to current forms of immunotherapy.
English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
Urdu